Prognostic value of risk scoring systems for cirrhotic patients with variceal bleeding

doi:10.3748/wjg.v25.i45.6668

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 45

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10539)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

676

WORD

179

HTML

6473

Figures (1-2)

357

Tables (1-4)

270

Sum=7955

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

839

Download

1745

Sum=2584

Dec 7, 2019 (publication date) through Feb 4, 2025

Times Cited of This Article

Times Cited (27)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Dec 7, 2019; 25(45): 6668-6680
Published online Dec 7, 2019. doi: 10.3748/wjg.v25.i45.6668

Table 1 Baseline characteristics of the included patients

Variables	Value
No. of patients	330
Age, mean ± SD, yr	54.9 ± 12.7
Male sex, n (%)	203 (61.5)
Etiology, n (%)
Viral	229 (69.4)
Alcohol	21 (6.4)
Autoimmune	34 (10.3)
Other	46 (13.9)
Laboratory tests, median (IQR)
White blood cells (10⁹/L)	5.4 (3.6-7.8)
Hemoglobin (g/L)	80 (66-95)
Platelets (10⁹/L)	77 (51-115)
INR	1.2 (1.1-1.4)
Total bilirubin (µmol/L)	22.6 (16.1-34.8)
ALT (IU/L)	23 (15-38)
AST (IU/L)	35 (25-56)
Albumin (g/L)	31.8 (28.4-35.3)
BUN (mmol/L)	8.7 (6.1-12.4)
Creatinine (µmol/L)	62.2 (48.5-77.2)
Sodium (mmol/L)	138.0 (134.9-140.3)
Vital signs, median (IQR)
SBP (mmHg)	110 (98-120)
DBP (mmHg)	65 (57-72)
Heart rate (beats/min)	88 (76-101)
Location of variceal bleeding, n (%)
Esophageal varices	295 (89.4)
Gastric varices	35 (10.6)
Grading of esophageal varices
Mild/ moderate/severe, n (%)	2 (0.7)/44 (14.9)/249 (84.4)
Types of gastric varices
GOV2/IGV1, n (%)	22 (62.9)/13 (37.1)
Ascites, n (%)	233 (70.6)
Hepatic encephalopathy, n (%)	28 (8.5)
Hepatocellular carcinoma, n (%)	73 (22.1)
Bacterial infection, n (%)	63 (19.1)
Portal vein thrombosis, n (%)	97 (29.4)
Hospital intervention, n (%)
Endoscopic therapy	141 (42.7)
TIPSS	21 (6.4)
Surgery	21 (6.4)
Charlson comorbidity index > 6, n (%)	45 (13.6)
Hospital stay (d), median (IQR)	13 (9-20)
Scoring system, median (IQR)
CTP	7 (6-9)
CTP grade A/B/C, n (%)	101 (30.6)/187 (56.7)/42 (12.7)
MELD	10 (9-13)
MELD-Na	12 (10-16)
CRS	2 (1-3)
GBS	12 (9-14)
mGBS	9 (7-11)
AIMS65	1 (0-1)
CANUKA	10 (8-12)

IQR: Interquartile range; INR: International normalized ratio; ALT: Alanine transaminase; AST: Aspartate transaminase; BUN: Blood urea nitrogen; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; GOV2: Type 2 gastroesophageal varices; IGV1: Type 1 isolated gastric varices; TIPSS: Transjugular intrahepatic portosystemic stent shunt; CTP: Child-Turcotte-Pugh score; MELD: Model for end-stage liver disease; CRS: Clinical Rockall score; GBS: Glasgow-Blatchford score; mGBS: Modiﬁed Glasgow-Blatchford score; AIMS65: AIMS65 score; CANUKA: Canada-United Kingdom-Australia score.

Citation: Tantai XX, Liu N, Yang LB, Wei ZC, Xiao CL, Song YH, Wang JH. Prognostic value of risk scoring systems for cirrhotic patients with variceal bleeding. World J Gastroenterol 2019; 25(45): 6668-6680
URL: https://www.wjgnet.com/1007-9327/full/v25/i45/6668.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i45.6668